Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

Antikainen RL, Peters R, Beckett NS, Fagard RH, Wang JG, Rajkumar C, Bulpitt CJ.

J Hypertens. 2016 Aug 23. [Epub ahead of print]

PMID:
27552643
2.

Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial.

Bulpitt CJ, Webb R, Beckett N, Peters R, Cheek E, Anderson C, Antikainen R, Staessen JA, Rajkumar C.

Blood Press. 2016 Aug 22:1-6. [Epub ahead of print]

PMID:
27546817
3.

Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials.

Yasar S, Schuchman M, Peters J, Anstey KJ, Carlson MC, Peters R.

Curr Hypertens Rep. 2016 Aug;18(8):67. doi: 10.1007/s11906-016-0674-1. Review.

PMID:
27492370
4.

Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies.

Peters R, Schuchman M, Peters J, Carlson MC, Yasar S.

Curr Hypertens Rep. 2016 Aug;18(8):66. doi: 10.1007/s11906-016-0673-2. Review.

PMID:
27492369
5.

Corrigendum to 'The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies'.

Pedditzi E, Peters R, Beckett N.

Age Ageing. 2016 May 25. pii: afw095. [Epub ahead of print] No abstract available.

PMID:
27225015
6.
7.

Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia.

Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, Beiser A, Borenstein AR, Crane PK, Haan M, Hassing LB, Hayden KM, Kiyohara Y, Larson EB, Li CY, Ninomiya T, Ohara T, Peters R, Russ TC, Seshadri S, Strand BH, Walker R, Xu W, Huxley RR.

Diabetes Care. 2016 Feb;39(2):300-7. doi: 10.2337/dc15-1588. Epub 2015 Dec 17.

PMID:
26681727
8.

Enhancing Community-Based Participatory Research Partnerships Through Appreciative Inquiry.

Paige C, Peters R, Parkhurst M, Beck LL, Hui B, May VT, Tanjasiri SP.

Prog Community Health Partnersh. 2015 Autumn;9(3):457-63. doi: 10.1353/cpr.2015.0054.

PMID:
26548798
9.

Literature review of visual representation of the results of benefit-risk assessments of medicinal products.

Hallgreen CE, Mt-Isa S, Lieftucht A, Phillips LD, Hughes D, Talbot S, Asiimwe A, Downey G, Genov G, Hermann R, Noel R, Peters R, Micaleff A, Tzoulaki I, Ashby D; PROTECT Benefit-Risk group.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):238-50. doi: 10.1002/pds.3880. Epub 2015 Nov 2. Review.

PMID:
26521865
10.

A Cluster-Randomized Controlled Intervention Study to Assess the Effect of a Contact Intervention in Reducing Leprosy-Related Stigma in Indonesia.

Peters RM, Dadun, Zweekhorst MB, Bunders JF, Irwanto, van Brakel WH.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004003. doi: 10.1371/journal.pntd.0004003. eCollection 2015.

11.

Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - the Newcastle 85+ Study.

Peters R, Collerton J, Granic A, Davies K, Kirkwood T, Jagger C.

J Hypertens. 2015 Oct;33(10):2156-64. doi: 10.1097/HJH.0000000000000653.

PMID:
26237554
12.

Is air pollution associated with increased risk of cognitive decline? A systematic review.

Peters R, Peters J, Booth A, Mudway I.

Age Ageing. 2015 Sep;44(5):755-60. doi: 10.1093/ageing/afv087. Epub 2015 Jul 18. Review.

PMID:
26188335
13.

Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review.

Peters J, Booth A, Peters R.

Ther Adv Chronic Dis. 2015 Jul;6(4):160-9. doi: 10.1177/2040622315582353.

14.

Lay and peer counsellors to reduce leprosy-related stigma--lessons learnt in Cirebon, Indonesia.

Lusli M, Peters RM, Zweekhorst MB, Van Brakel WH, Seda FS, Bunders JF, Irwanto.

Lepr Rev. 2015 Mar;86(1):37-53.

PMID:
26065146
15.

Dealing with stigma: experiences of persons affected by disabilities and leprosy.

Lusli M, Zweekhorst MB, Miranda-Galarza B, Peters RM, Cummings S, Seda FS, Bunders JF, Irwanto.

Biomed Res Int. 2015;2015:261329. doi: 10.1155/2015/261329. Epub 2015 Apr 15.

17.

The cultural validation of two scales to assess social stigma in leprosy.

Peters RM, Dadun, Van Brakel WH, Zweekhorst MB, Damayanti R, Bunders JF, Irwanto.

PLoS Negl Trop Dis. 2014 Nov 6;8(11):e3274. doi: 10.1371/journal.pntd.0003274. eCollection 2014.

18.

A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly.

Peters R, Booth A, Peters J.

J Hypertens. 2014 Oct;32(10):1945-57; discussion 1957-8. doi: 10.1097/HJH.0000000000000273. Review.

PMID:
25068540
19.

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

Hallgreen CE, van den Ham HA, Mt-Isa S, Ashworth S, Hermann R, Hobbiger S, Luciani D, Micaleff A, Thomson A, Wang N, van Staa TP, Downey G, Hirsch I, Hockley K, Juhaeri J, Metcalf M, Mwangi J, Nixon R, Peters R, Stoeckert I, Waddingham E, Tzoulaki I, Ashby D, Wise L.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):974-83. doi: 10.1002/pds.3676. Epub 2014 Jul 5.

PMID:
25043919
20.

Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial.

Beckett N, Peters R, Leonetti G, Duggan J, Fagard R, Thijs L, Narkiewicz K, McCormack T, Banya W, Fletcher A, Bulpitt C; HYVET Study Group.

J Hypertens. 2014 Jul;32(7):1478-87; discussion 1487. doi: 10.1097/HJH.0000000000000195.

PMID:
24984177
Items per page

Supplemental Content

Loading ...
Write to the Help Desk